GenSight Biologics S.A. | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
40.30
255.60
138.70
202.60
224.00
-
Gross Income
40.30
255.60
138.70
202.60
224.00
-
SG&A Expense
3,706.50
7,590.30
17,082.60
24,816.80
27,468.00
37,400
EBIT
3,746.80
7,845.90
17,221.30
-
27,692.00
33,700
Non Operating Income/Expense
75.50
72.00
693.60
63.00
112.00
-
Pretax Income
3,671.30
7,773.80
16,527.70
25,011.50
27,804.00
-
Income Tax
908.40
1,102.70
2,874.10
2,929.90
3,692.00
-
Consolidated Net Income
2,762.90
6,671.10
13,653.60
22,081.70
24,112.00
33,500
Net Income
2,762.90
6,671.10
13,653.60
22,081.70
24,112.00
33,500
Net Income After Extraordinaries
2,762.90
6,671.10
13,653.60
22,081.70
24,112.00
33,500
Net Income Available to Common
2,762.90
6,671.10
13,653.60
22,081.70
24,112.00
33,500
EPS (Basic)
0.16
0.30
1.21
1.36
1.10
1.37
Basic Shares Outstanding
18,956.60
18,956.60
18,956.60
16,252.80
21,936.00
-
EPS (Diluted)
0.15
0.35
0.72
1.36
1.10
-
Diluted Shares Outstanding
18,956.60
18,956.60
18,956.60
16,252.80
21,936.00
-
EBITDA
3,706.50
7,590.30
17,082.60
24,746.00
27,468.00
-
Other Operating Expense
-
-
-
70.80
-
3,700
About GenSight Biologics
View Profile
